Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 200.79

-0.2%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (20651)	5/13/1998 8:54:00 AM
From: squetch	Read Replies (1) of 32384

Henry, I have not seen the abstract. The issue of risk using Tamoxifen seems slightly up in the air to me due to conflicting studies. Another one at ASCO might help clear things. The effect of tamoxifen on the risk and prognosis of endometrial cancer following breast cancer: a study with 309 cases. Did you see the med correspondent for Today this am? I guess he was talking raloxifene. At the end he mentioned looking if they can use it in combo for bcancer prevention per my wife. She said he just mentioned the class of drugs, but couldn't recall. She thought it started w/ an A when asked. Agonists, she wasn't sure. The doctor said POTENTIALLY could lower breast cancer rates to those men. [EDIT: I feel like I should start including Save Harbor statements in posts like this.]

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next